2021-01-04,b'$UTHR Wedbush Stick to Their Buy Rating for United Therapeutics Corp. $255 PT https://t.co/5ANjwoA0OB'
2021-01-04,b'$UTHR United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference https://t.co/sTtSBOhk4s via @HeraldMailNews'
2021-01-04,b'$UTHR #United Therapeutics Corp. PRV Bought for $105M Creates Expedited Regulatory Review for Tyvaso DPI\xe2\x84\xa2: [...] https://t.co/AWsPiGl3fG #equity #stocks https://t.co/V1zdjdtka5'
2021-01-04,"b'Compared to an average industry price book ratio of 4.20, $UTHR is valued rather cheaply. https://t.co/tnBHxoXWwI https://t.co/kkr2TRQ62w'"
2021-01-04,b'RT @TheStockWire: $UTHR\nUnited Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference'
2021-01-04,b'United Therapeutics To Present At The 39th Annual J.P. Morgan Healthcare Conference $UTHR https://t.co/f3UA59IZI1'
2021-01-04,b'$UTHR United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference https://t.co/g2nvHL0Gxw'
2021-01-04,b'$UTHR\nUnited Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference'
2021-01-04,b'$UTHR United Therapeutics Corporation To Present At The 39th Annual J.P. Morgan Healthcare Conference\nhttps://t.co/gNiNpGR7n0'
2021-01-03,"b""Biotech '21 Watchlist \n$Crspr $ilmn $pacb $ntla \n$Edit $Glsi $Blue $scps $glsi \n$Sgmo $Uthr $Vrtx \n\nI feel like a lot of attention will be put on bio tech moving forward.The worlds main focus should clearly be on our health and how we can prevent a repeat of 2020. Share your WL!"""
2021-01-03,b'$UTHR definitely going to finish over $166.97  2.09 % change recently https://t.co/VzFstzpu4I'
2021-01-03,b'$SNRG to get massive exposure following next weeks scheduled segment on CNBC Squawk Box\nhttps://t.co/fK8PPZ6hwp\n\n$ATKR $SERV $EVH $SRUP $CYD $HPP $UTHR $APPS $APHQF $FGEN $IRBL $EPXY $TONR'
2021-01-03,"b'In the last month $UTHR has a been trading in the 129.43 - 152.82 range, which is quite wide. https://t.co/zvL49n4U6W https://t.co/XFizlk6LhH'"
2021-01-02,"b""$UTHR Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe.  2.09 % change recently https://t.co/slh823ceSP"""
2021-01-02,b'$UTHR this is capitalism 2.09 % change recently https://t.co/slh823ceSP'
2021-01-02,b'$UTHR auction is now open. 2.09 % change recently https://t.co/fMLTtJQ8Sb'
2021-01-01,b'$UTHR  significant price movement on this stock 2.09 % change recently https://t.co/slh823ceSP'
2021-01-01,b'A few New Highs names to watch \n$LFUS $SYK $IAC $ALGT $UTHR $ADI $TMUS $ADUS $CCK $MXIM'
2021-01-01,b'$UTHR price movement 2.20 % https://t.co/fMLTtJQ8Sb'
2021-01-01,b'$BTK US ARCA Biotechnology top: $UTHR $BIIB $GILD $EXEL. Selected by our stock screener: https://t.co/J6q5BTTvwJ #stocks  #valueinvesting #valuation'
2021-01-01,b'Top 15 Pharmaceuticals stocks with market cap over 1 billion today. \n\nhttps://t.co/ZX9PwL80hF\n\n$IMAB $TRIL $PMVP $ALGS $PRAX $STOK $ARVN $GILD $SWAV $GH $UTHR $CYTK $PCRX $OCUL $ABBV\n\n\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80\xf0\x9f\x9a\x80 https://t.co/OZzJbIJN0m'
2020-12-31,b'Biotech/HC New or revisited 52-Week Highs: $ADUS $ZLAB $BASI $EIDX $APLS $ENDP $INCR $JAZZ $JNJ $NXTM $OTIC $PRAH $SLDB $SKLN $SYK $TCON $TFX $UTHR $VCEL $VTGN'
2020-12-31,b'New 52 Week High today: $STAY $MTA $UTHR $RDVY $GPN $TFX $JNJ ... https://t.co/4Iw0QeR3p8'
2020-12-31,"b'Daily #Biotech Pulse: Osmotica Faces 2nd FDA Rejection, UK Cond. Approves AstraZenecavVaccine Candidate, Hepion NASH Data.. New Highs: $ABMD $APLS $AVIR $BASI $BNGO $CLPT $DMTK $EW $NARI $LUMO $MRSN $ORGO $PRAX $SBTX $SPRO $TENX $TCON $TMDI $UTHR $XTLB \nhttps://t.co/yvLqLV6i5H'"
2020-12-30,"b'$TKOI OVERSOLD, microscopic float big money loading\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/lbfMVqYawA'"
2020-12-30,"b'Stocks that traded to 52 week highs: $TTWO, $UIS, $UTHR, $V, $VCEL, $WMS, $YUM'"
2020-12-30,b'$RUI US Russell 1000 Index top: $EQC $BIO $SNX $UTHR. Selected by our stock screener: https://t.co/xFwGCreVOK #stocks  #valueinvesting #valuation'
2020-12-30,b'Drug tech is already an FDA approved tech in market for 5 years and currently in partnership with $UTHR tyvaso dpi $1b+ drug.'
2020-12-29,b'RT @_B_I_O_T_E_C_H_: $YMAB sold PRV to $UTHR for $105M\n\n---&gt; $MRNS should be at $20 now'
2020-12-29,b'Biotech/HC New or revisited 52-Week Highs: $ABMD $BASI $APLS $MRSN $CYTR $DVA $ERB $INCR $NXTM $SKLN $TCON $UTHR $QQQ'
2020-12-29,"b'Stocks that traded to 52 week highs: $KTOS, $MNR, $MNST, $MORN, $NTGR, $ORA, $ORGO, $PEP, $POWI, $RCM, $SCHW, $SCVL, $SPB, $STZ, $TJX, $TRMB, $UIS, $UTHR, $VRSK, $XYL, $YUM'"
2020-12-29,b'RT @Stocktr96494225: $DLOC OVERSOLD! 1 MILLION FLOAT!!!\xf0\x9f\x92\xb8\xf0\x9f\x9b\x92\xf0\x9f\x93\x88\xf0\x9f\x8d\xbe\xe2\x9c\x88\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $\xe2\x80\xa6'
2020-12-29,"b""United Therapeutics' treprostinil development uses MannKind technology, say BTIG\n$MNKD $UTHR"""
2020-12-28,b'$UTHR United Therapeutics Corporation SEC Filing: Form 4 https://t.co/YbWFxJQZLD'
2020-12-28,b'Biotech/HC New or revisited 52-Week Highs: $ACRS $ALLK $ATEC $ATRC $BASI $SPRO $CLLS $APLS $CNMD $CRIS $CYTR $EPIX $ERB $IDXX $INCR $JAZZ $KMPH $LAKE $NTLA $NTRA $NVCR $NXTM $SAGE $SGMO $SKLN $SMLR $TECH $UTHR $VCEL $XOMA $QQQ'
2020-12-28,b'RT @MauriceOnTW: I guess the market is seeing the negative side to this for $LQDA today to me I read the opposite $UTHR feels urgency to tr\xe2\x80\xa6'
2020-12-28,"b'RT @StuckInStock: $UTHR continues on the offensive as it buys a U.S. FDA priority-review voucher for $105 million for its Tyvaso DPI NDA, w\xe2\x80\xa6'"
2020-12-28,b'I guess the market is seeing the negative side to this for $LQDA today to me I read the opposite $UTHR feels urgency to try to beat $LQDA to market!\nIf they want to sell implication were offer way too low to reach agreement with bidder (UTHR?) still other big PAH player too https://t.co/SK8j95tXSA'
2020-12-28,"b'$UTHR continues on the offensive as it buys a U.S. FDA priority-review voucher for $105 million for its Tyvaso DPI NDA, which it expects to file in the first half of 2021, hurting $LQDA further with shares down 9%'"
2020-12-28,b'$DLOC OVERSOLD! 1 MILLION FLOAT!!!\xf0\x9f\x92\xb8\xf0\x9f\x9b\x92\xf0\x9f\x93\x88\xf0\x9f\x8d\xbe\xe2\x9c\x88\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/p9OF4JavZu'
2020-12-28,"b'Stocks that traded to 52 week highs: $USAT, $UTHR, $VCEL, $VRNT, $VVV, $WCC, $WETF, $WMS, $WOW, $WSFS, $WTS, $XPER, $XYL, $ZEN'"
2020-12-28,"b'$uthr looks undervalued, trading at p/s under 5, forward p/e of 12.'"
2020-12-28,"b""$MNKD $UTHR They want to beat Liquidia to market as Liquidia must have a  knockoff of the Treprostinal being a generic drug.  So Martine wants to make sure they don't lose any market share especially with a blockbuster deliver... https://t.co/kgDYz7NSos"""
2020-12-28,b'RT @TheHarryx1: United Therapeutics $UTHR purchases Priority Review Voucher to be applied to the forthcoming NDA for Tyvaso DPI\xe2\x84\xa2 (Trepostin\xe2\x80\xa6'
2020-12-28,b'RT @TheHarryx1: United Therapeutics $UTHR purchases Priority Review Voucher to be applied to the forthcoming NDA for Tyvaso DPI\xe2\x84\xa2 (Trepostin\xe2\x80\xa6'
2020-12-28,b'$UTHR Phase 1 Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells\xe2\x80\xa6NCT02573896. Estimated Primary Completion Date -  01/2021'
2020-12-28,"b'$UTHR Phase 1 Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso\xe2\x80\xa6NCT03950739. Estimated Primary Completion Date -  01/2021'"
2020-12-28,"b""added $MNKD 3.35\n\ncatalysts here haven't changed and the $UTHR PR today only strengthens case"""
2020-12-28,b'RT @TheHarryx1: United Therapeutics $UTHR purchases Priority Review Voucher to be applied to the forthcoming NDA for Tyvaso DPI\xe2\x84\xa2 (Trepostin\xe2\x80\xa6'
2020-12-28,b'RT @_B_I_O_T_E_C_H_: $YMAB sold PRV to $UTHR for $105M\n\n---&gt; $MRNS should be at $20 now https://t.co/w5GzKvr09m'
2020-12-28,b'United Therapeutics $UTHR purchases Priority Review Voucher to be applied to the forthcoming NDA for Tyvaso DPI\xe2\x84\xa2 (Trepostinil Technosphere) $MNKD\n\nhttps://t.co/xaulzbKlSb\n\n#PAH #Lungs #Innovation #Technosphere #DrugDelivery #MedTwitter https://t.co/smtIijYUxQ'
2020-12-28,b'United Therapeutics Buys Priority Review Voucher for $105M https://t.co/fnZw5tDOkI #markets #trading #stocks $UTHR'
2020-12-28,b'$YMAB $UTHR Y-mAbs Announces Sale of Priority Review Voucher https://t.co/gd1uN466PQ'
2020-12-28,b'\xf0\x9f\x94\x94\xf0\x9f\x94\x94\n$UTHR to acquire priority review voucher for $105M.\n$BABA increases stock buyback plan to $10B.\n$PYPL play for BitGo falls through.'
2020-12-28,b'RT @invest_tran: $UTHR to acquire priority review voucher for $105M.\n$BABA increases stock buyback plan to $10B.\n$PYPL play for BitGo falls\xe2\x80\xa6'
2020-12-28,b'$UTHR to acquire priority review voucher for $105M.\n$BABA increases stock buyback plan to $10B.\n$PYPL play for BitGo falls through.'
2020-12-28,b'$UTHR  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 96'
2020-12-28,b'$UTHR  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 95'
2020-12-28,b'$UTHR United Therapeutics Agrees To Acquire Priority Review Voucher https://t.co/ygbTLhZX8W'
2020-12-28,b'RT @mediasentiment: $UTHR  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 88'
2020-12-28,"b'@Kiran35654509 also, $MNKD on the $UTHR priority review voucher news regarding Tyvaso'"
2020-12-28,b'$YMAB sold PRV to $UTHR for $105M\n\n---&gt; $MRNS should be at $20 now https://t.co/w5GzKvr09m'
2020-12-28,b'$UTHR  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 88'
2020-12-28,b'to $UTHR for $105 million'
2020-12-28,b'Y-mAbs Therapeutics announces sale of priority review voucher \n$YMAB $UTHR'
2020-12-28,b'$YMAB to sell its Priority Review Voucher to $UTHR       #YmAbsTherapeutics      #UnitedTherapeutics    https://t.co/TBJuj9035H'
2020-12-28,b'$UTHR Announces Agreement To Acquire Priority Review Voucher\nhttps://t.co/Oxi79NLY2D'
2020-12-28,b'$UTHR (+0.0% pre) United Therapeutics to acquire priority review voucher for $105M - SA\n\nhttps://t.co/KsoAeOJoDM'
2020-12-28,b'$UTHR: United Therapeutics announces agreement to acquire priority review voucher https://t.co/xaXhta3Cty'
2020-12-28,"b'RT @BioStocks: $UTHR Announces Agreement To Acquire Priority Review Voucher For $105M.\nIntends to apply the PRV to its NDA for Tyvaso DPI,\xe2\x80\xa6'"
2020-12-28,"b'RT @BioStocks: $UTHR Announces Agreement To Acquire Priority Review Voucher For $105M.\nIntends to apply the PRV to its NDA for Tyvaso DPI,\xe2\x80\xa6'"
2020-12-28,"b'$UTHR - United Therapeutics (NASDAQ:UTHR) inks agreement to purchase a Rare Pediatric Disease Priority Review Voucher (PRV) for $105M to use with a forthcoming New Drug Application (NDA) for Tyvaso DPI, expected in H1 2021.\n\nJust reported \xf0\x9f\x92\xaa'"
2020-12-28,b'$UTHR Announces Agreement To Acquire Priority Review Voucher\n\n$105m'
2020-12-28,b'RT @MarketCurrents: $UTHR $MNKD - United Therapeutics to acquire priority review voucher for $105M https://t.co/knT2eed8vU'
2020-12-28,b'RT @MarketCurrents: $UTHR $MNKD - United Therapeutics to acquire priority review voucher for $105M https://t.co/knT2eed8vU'
2020-12-28,b'$UTHR $MNKD - United Therapeutics to acquire priority review voucher for $105M https://t.co/knT2eed8vU'
2020-12-28,b'$UTHR to acquire Priority Review Voucher - expected to be applied to the forthcoming NDA for Tyvaso DP     #UnitedTherapeutics     https://t.co/JFBDOyOFPg'
2020-12-28,"b'RT @BioStocks: $UTHR Announces Agreement To Acquire Priority Review Voucher For $105M.\nIntends to apply the PRV to its NDA for Tyvaso DPI,\xe2\x80\xa6'"
2020-12-28,b'$UTHR United Therapeutics Corporation SEC Filing: Form 8-K https://t.co/qU87z2I2ap'
2020-12-28,"b'$UTHR / United Therapeutics files form 8-K - Financial Statements and Exhibits, Other Events -  FORM 8-K https://t.co/DCn9lXjnzv'"
2020-12-28,b'New Form 8-K [Press/News Current Report] entry filed by  $UTHR UNITED THERAPEUTICS Corp  https://t.co/IOjbBGZbOL'
2020-12-28,b'United Therapeutics to acquire PRV for Tyvaso DPI NDA\n$UTHR'
2020-12-28,"b""$UTHR Announces Agreement To Acquire Priority Review Voucher For $105M.\nIntends to apply the PRV to its NDA for Tyvaso DPI, expected in 1H'21"""
2020-12-28,b'$UTHR\nUnited Therapeutics Announces Agreement To Acquire Priority Review Voucher'
2020-12-28,b'$UTHR United Therapeutics Announces Agreement To Acquire Priority Review Voucher\nhttps://t.co/pVTy7mLQud'
2020-12-28,"b'$TKOI OVERSOLD, microscopic float big money loading\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/lbfMVqYawA'"
2020-12-28,b'$WSGF OVERSOLD! the next airbnb\xf0\x9f\x92\xb8 \n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/OwrGvf7h7o'
2020-12-28,b'$UAPC OVERSOLD! next #MARIJUANA STOCK TO FLY\xf0\x9f\x92\xb8\xe2\x9c\x88\xf0\x9f\x93\x88\n\n$RDUS $UTHR $PTLA $ALDR $OPK $GLPG $ARWR $ONCS $MTEM $SGYP $NEPT $ASMB $JNJ $MRK $AAPL $GOOG $INTC $CLDX $MSFT $CMCSA $PFE $MU $NFLX $NOK $XO $DIS $NVDA $BAC $AMD $WMT $CHK $AKS $VZ $CTL $FCX $T $JPM $WFT $NVCN $BIDU $HPQ $P $F https://t.co/T9KnDbJnqB'
2021-01-08,b'$UTHR United Therapeutics Corpo Top stock up 110% from low. Close: 167.05 VolvsAvg: 1.75 Liq: $102M https://t.co/t9RWGulAkK'
2021-01-08,b'$UTHR United Therapeutics Corpo #Monster #Volume #Stock $SPY $SPX $QQQ 167.05 VolvsAvg: 1.75 Liq: $102M https://t.co/t9RWGulAkK'
2021-01-07,b'2/2 Biotech/HC New or revisited 52-Week Highs:  $PLSE $CDMO $PRAH $PRPH $PTCT $IQV $RDUS $SAGE $SEM $SGRY $SLDB $SKLN $STE $TECH $UTHR $VBLT $VCEL $VTGN $WCG $XNCR $SPY $QQQ'
2021-01-07,b'$UTHR price movement 4.30 % https://t.co/fMLTtJQ8Sb'
2021-01-07,b'New 52 Week High today: $AN $YOLO $MDYV $FNDX $CSV $XRT $CREE $DAN $TRTN $CADE $SCHW $UTHR $NTES $CFX $LPL $RYTM $HUN $RIOT $CRON $PRAH ... https://t.co/4Iw0QeR3p8'
2021-01-07,b'$UTHR the valuation looks good  \xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd\xef\xbf\xbd 4.30 % change recently https://t.co/slh823ceSP'
2021-01-07,b'$UTHR United Therapeutics Corpo Top stock up 106% from low. Close: 163.51 VolvsAvg: 1.92 Liq: $100M https://t.co/t9RWGulAkK'
